Home
/
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL) Technical Analysis
Updated: 2026-03-17 00:37 UTC · Last close: 2.71 (+0.00%)
Zentalis Pharmaceuticals, Inc. (ZNTL) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Zentalis Pharmaceuticals, Inc. (ZNTL) finished the session at 2.71 (+0.00%). Broadly speaking, trend structure still looks constructive because price remains above both the 50-day and 200-day averages. 20-day momentum is notably strong at +13.39%; price remains inside its roughly 52-week range (1.04–3.74); and ATR14 volatility is elevated at roughly 8.63% of price. RSI(14) stands around 54.5, which keeps the momentum picture broadly balanced. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Pattern signals currently detected: pat_hs. On the downside, 2.42 is the first support area. Holding above it helps keep the current structure more stable. On the fundamentals side, the latest snapshot shows Net income: -101.84M · EPS (basic): -1.42. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.
Fundamentals Snapshot
Source: sec
Company
Zentalis Pharmaceuticals, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).